Investing Profile

Andrew Bayliffe

InvestorVC

Venture Partner at Apple Tree Partners

appletreepartners.com/teamLondon

Your Intro Paths to Andrew Bayliffe

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Andrew is a member of

GSK Network

45 CONNECTIONS

GSK Network

45 CONNECTIONS

GSK Network

45 CONNECTIONS

GSK Network

45 CONNECTIONS

GSK Network

45 CONNECTIONS

Find Andrew Bayliffe on

Current Investing Position

ATP (Apple Tree Partners) Venture Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Andrew Bayliffe is on these Sector & Stage Rankings

Medical Devices (Series A)Pharmaceuticals (Series A)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)London Digital Health (Series A)

Andrew Bayliffe's Investments On Record (1)

Company	StageDateRound Size	Total Raised
Marengo Therapeutics	Series BNov 2021$80M	$80M
Co-investors: Joseph A. Yanchik III (ATP (Apple Tree Partners)), Rajesh Chopra (ATP (Apple Tree Partners))

Andrew Bayliffe's Experience

Venture Partner Apple Tree Partners2019 - Present

Research Scientist, Pharmacogenetics & Applied Diagnostics GlaxoSmithKlinePresent

Translational Scientist - Clinical Pharmacology & Experimental Medicine GlaxoSmithKlinePresent

Clinical Pharmacology Leader - Immunology & Inflammation R&D GlaxoSmithKlinePresent

Clinical Pharmacology Leader - Biopharmaceuticals R&D GlaxoSmithKlinePresent

Head, Translational Medicine - Biopharmaceuticals Innovation Unit GlaxoSmithKlinePresent

Global Development Leader - Respiratory & Inflammation GlaxoSmithKlinePresent

Head, Respiratory and Inflammation Research Unit GlaxoSmithKlinePresent

Chief Development Officer (CDO) Quotient TherapeuticsPresent

Venture Partner ATP (Apple Tree Partners)Present

Chief Scientific Officer Marengo Therapeutics2020 - 2025

Head, Respiratory and Inflammation Research Unit GSK2015 - 2020

Global Development Leader - Respiratory & Inflammation GSK2013 - 2015

Head, Translational Medicine - Biopharmaceuticals Innovation Unit GSK2011 - 2013

Clinical Pharmacology Leader - Biopharmaceuticals R&D GSK2008 - 2011

Clinical Pharmacology Leader - Immunology & Inflammation R&D GSK2004 - 2008

Translational Scientist - Clinical Pharmacology & Experimental Medicine GSK2002 - 2004

Research Scientist, Pharmacogenetics & Applied Diagnostics GSK2000 - 2002

Research Scientist AstraZeneca1998 - 2000

Andrew Bayliffe's Education

The Manchester Metropolitan University Bachelor of Science - BS Pharmacology

University of Leeds Doctor of Philosophy - PhD Pharmacology and Molecular Biology

Investors who invest with Andrew Bayliffe

Scouts & Angels Affiliated With Andrew Bayliffe